X Close
TMCnet - World's Largest Communications and Technology Community



Research and Markets: Asia Pacific Cardiovascular Diseases Therapeutics Market 2013-2019
[April 11, 2014]

Research and Markets: Asia Pacific Cardiovascular Diseases Therapeutics Market 2013-2019

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/bqfdcg/cardiovascular) has announced the addition of the "Asia Pacific Cardiovascular Diseases Therapeutics Market 2013-2019" report to their offering.

The value of the CVD market in India, Australia, China and Japan amounted to an estimated $7.61 billion in 2012, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 1.4% over the forecast period to reach $8.39 billion in 2019

Asia Pacific Cardiovascular Diseases Therapeutics Market 2013-2019 provides insights into three cardiovascular therapeutic indications in in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namelyheart failure, myocardial infarction (MI), acute coronary syndrome (ACS (News - Alert)).

The market for Cardiovascular Disease (CVD) - comprising heart failure, myocardial infarction and Acute Coronary Syndrome (ACS) - has registered modest growth from 2007-2012 the period due to the launch of various blockbuster drugs. The market is expected to grow at a gradual rate over the forecast period from 2012 to 2019, due to the patent expiry of a number of blockbuster drugs, including Lipitor (atorvastatin) and Plavix (clopidogrel).

The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indications.


  • Disease overview and treatment usage patterns
  • Market size and forecast for heart failure, MI and ACS in APAC market from 2012 to 2019
  • Major marketed products for the indications types covered
  • In-depth pipeline analysis for heart failure, MI and ACS
  • Key drivers and restraints that have had and are expected to have a significant impact upon the market
  • Key licensing and co-development agreements in the cardiovascular market

Key Topics Covered:

  1. Tables & Figures
  2. Introduction
  3. Therapeutic Landscape
  4. Marketed Products
  5. Pipeline Analysis
  6. Market Forecast to 2019
  7. Deals and Strategic Consolidations
  8. Appendix

For more information visit http://www.researchandmarkets.com/research/bqfdcg/cardiovascular

[ Back To TMCnet.com's Homepage ]

Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.


© 2015 Technology Marketing Corporation. All rights reserved | Privacy Policy